In conclusion, dissecting the impact of GPS2 deletion in breast cancer cells has highlighted the central role of the TRAF6/Ubc13 ubiquitin machinery in coordinating signaling pathways across subcellular compartments and revealed that the dysregulation of ubiquitination could represent a critical factor in cancer growth and metabolic adaptation. The gene discussed is UBE2N; the disease is breast carcinoma.